Nivolumab for treating advanced (unresectable or metastatic) melanoma
Nivolumab for treating advanced (unresectable or metastatic) melanoma
Systematic review, nivolumab, melanoma, unresectable, metastatic
National Institute for Health and Care Research
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Streit, Elke
b32d5462-990c-45f4-b36d-585f8e8eb3f5
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67
Chorozoglou, Maria
1d8dc56f-914a-402a-8155-4fb1e4380835
Frampton, Geoffrey
26c6163c-3428-45b8-b8b9-92091ff6c69f
3 February 2016
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Streit, Elke
b32d5462-990c-45f4-b36d-585f8e8eb3f5
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67
Chorozoglou, Maria
1d8dc56f-914a-402a-8155-4fb1e4380835
Frampton, Geoffrey
26c6163c-3428-45b8-b8b9-92091ff6c69f
Cooper, Keith, Kalita, Neelam, Streit, Elke, Shepherd, Jonathan, Chorozoglou, Maria and Frampton, Geoffrey
(2016)
Nivolumab for treating advanced (unresectable or metastatic) melanoma
(Health Technology Assessment, HTA - 15/06/11)
National Institute for Health and Care Research
115pp.
Record type:
Monograph
(Project Report)
Text
Nivolumab for treating advanced unresectable or metastatic melanoma
Available under License Other.
Text
Nivolumab for treating advanced unresectable or metastatic melanoma Erratum
Available under License Other.
More information
Published date: 3 February 2016
Keywords:
Systematic review, nivolumab, melanoma, unresectable, metastatic
Organisations:
SHTAC
Identifiers
Local EPrints ID: 411981
URI: http://eprints.soton.ac.uk/id/eprint/411981
PURE UUID: 9b2ac664-8e24-49ae-9d17-3ce9c7dfa123
Catalogue record
Date deposited: 04 Jul 2017 16:31
Last modified: 10 Apr 2024 01:49
Export record
Contributors
Author:
Elke Streit
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics